Literature DB >> 27658769

Impact of a hand hygiene campaign in a tertiary hospital in South Korea on the rate of hospital-onset methicillin-resistant Staphylococcus aureus bacteremia and economic evaluation of the campaign.

June Young Chun1, Hye Kyung Seo2, Min-Kyung Kim1, Myoung Jin Shin2, Su Young Kim2, Moonsuk Kim1, Chung-Jong Kim1, Kyoung-Ho Song1, Eu Suk Kim1, Heeyoung Lee3, Hong Bin Kim4.   

Abstract

BACKGROUND: Hand hygiene (HH) is the most important factor affecting health care-associated infections.
METHODS: We introduced a World Health Organization HH campaign in October 2010. The monthly procurement of hand sanitizers per 1,000 patient days was calculated, and the monthly incidence of methicillin-resistant Staphylococcus aureus bacteremia (MRSAB), classified into community- and hospital-onset (HO), was measured from a microbiologic laboratory database. Trends of MRSAB incidence were assessed using Bayesian structural time series models. A cost-benefit analysis was also performed based on the economic burden of HO MRSAB in Korea.
RESULTS: Procurement of hand sanitizers increased 134% after the intervention (95% confidence interval [CI], 120%-149%), compared with the preintervention period (January 2008-September 2010). In the same manner, HH compliance improved from 33.2% in September 2010 to 92.2% after the intervention. The incidence of HO MRSAB per 100,000 patient days decreased 33% (95% CI, -57% to -7.8%) after the intervention. Because there was a calculated reduction of 65 HO MRSAB cases during the intervention period, the benefit outweighed the cost (total benefit [$851,565]/total cost [$167,495] = 5.08).
CONCLUSIONS: Implementation of the HH campaign led to increased compliance and significantly reduced HO MRSAB incidence; it was also cost saving. Copyright Â
© 2016 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacteremia; Cost-benefit analysis; Hand hygiene; Infection control; Methicillin-resistant Staphylococcus aureus; Nosocomial infection

Mesh:

Year:  2016        PMID: 27658769     DOI: 10.1016/j.ajic.2016.07.009

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  5 in total

1.  Stepwise Expansion of Antimicrobial Stewardship Programs and Its Impact on Antibiotic Use and Resistance Rates at a Tertiary Care Hospital in Korea.

Authors:  Dong Hoon Shin; Hyung-Sook Kim; Eunjeong Heo; Myoung-Jin Shin; Nak-Hyun Kim; Hyunju Lee; Jeong Su Park; Kyoung Un Park; Jongtak Jung; Kyoung-Ho Song; Minsun Kang; Jaehun Jung; Eu Suk Kim; Hong Bin Kim
Journal:  Microbiol Spectr       Date:  2022-04-25

2.  Effect of handrubbing using locally-manufactured alcohol-based handrubs in paediatric wards in Harare, Zimbabwe.

Authors:  Muchaneta Gudza-Mugabe; Marcelyn T Magwenzi; Hilda A Mujuru; Mutsa Bwakura-Dangarembizi; Valerie Robertson; Alexander M Aiken
Journal:  Antimicrob Resist Infect Control       Date:  2017-01-11       Impact factor: 4.887

3.  Transmission of methicillin-resistant Staphylococcus aureus in an acute care hospital in Japan.

Authors:  Kaori Matsumoto; Seisho Takeuchi; Yoshio Uehara; Masahide Matsushita; Kazumi Arise; Norihito Morimoto; Yusuke Yagi; Hiromi Seo
Journal:  J Gen Fam Med       Date:  2018-10-15

4.  Development and validation of a time and motion guide to assess the costs of prevention and control interventions for nosocomial infections: A Delphi method among experts.

Authors:  Eric Tchouaket Nguemeleu; Sandra Boivin; Stephanie Robins; Drissa Sia; Kelley Kilpatrick; Sylvain Brousseau; Bruno Dubreuil; Catherine Larouche; Natasha Parisien
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

5.  The effect of a 5-year hand hygiene initiative based on the WHO multimodal hand hygiene improvement strategy: an interrupted time-series study.

Authors:  Yumi Suzuki; Motoko Morino; Ichizo Morita; Shigenori Yamamoto
Journal:  Antimicrob Resist Infect Control       Date:  2020-05-27       Impact factor: 4.887

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.